We offer predictive drug discovery technologies which span the full breadth of research from target to candidate drug selection.  The core elements are fully integrated, enabling customers to access these end-to-end technologies, or individual components and services as required.

Our chemogenomics division, Chematica, includes consultancy, databases, and tools to aid target validation and drug discovery activities.  Chematica consists of three major products  - DrugStore, StARLITe, SARfari  - which are optimized for data-mining and integration of third-party data and consist of expertly curated information.

Our in silico optimization platform, StarDrop,  is an interactive platform which enables scientists to efficiently design, profile, identify and effectively prioritize compounds to achieve an optimal balance of properties at all stages of drug discovery. This intuitive desktop interface integrates predicted and experimental data, such as potency and selectivity measurements, enabling scientists to rapidly identify and design high quality compounds to meet their project’s objectives.